Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 10 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 07, 2022 Filed Jan 11, 2022 21:23 UTC |
Robinson William G JrDirector
|
Exercise / conversionClass A Common Stock | 27,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-000725 · wf-form4_164195418269205.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2022 Filed Jan 12, 2022 02:51 UTC |
Garipalli VivekDirector · Chief Executive Officer · 10% owner
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,342,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-000730 · wf-form4_164195588944291.xml · derivative · entry 3 Garipalli Vivek · CIK 0001839260 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,370,793 Underlying: Class B Common Stock · 3,342,698 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: On January 7, 2021, the Reporting Person was granted 16,713,491 RSUs, vesting in equal annual installments over five years, beginning on January 7, 2022, subject to the continuous service of the Reporting Person as CEO, Co-CEO or Executive Chairman of the Issuer through each vesting date. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person upon vesting. F2 · derivative.expiration_date: On January 7, 2021, the Reporting Person was granted 16,713,491 RSUs, vesting in equal annual installments over five years, beginning on January 7, 2022, subject to the continuous service of the Reporting Person as CEO, Co-CEO or Executive Chairman of the Issuer through each vesting date. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person upon vesting. F3 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. Read SEC document |
| January 07, 2022 Filed Jan 12, 2022 02:51 UTC |
Garipalli VivekDirector · Chief Executive Officer · 10% owner
|
Tax withholdingClass B Common Stock | 1,664,825 | $3.16 | $5,260,847.00 |
DisclosureSEC source: 0001628280-22-000730 · wf-form4_164195588944291.xml · nonDerivative · entry 2 Garipalli Vivek · CIK 0001839260 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,677,873 Read SEC document |
| January 07, 2022 Filed Jan 12, 2022 02:51 UTC |
Garipalli VivekDirector · Chief Executive Officer · 10% owner
|
Exercise / conversionClass B Common Stock | 3,342,698 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-000730 · wf-form4_164195588944291.xml · nonDerivative · entry 1 Garipalli Vivek · CIK 0001839260 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,342,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. Read SEC document |
| January 07, 2022 Filed Apr 27, 2023 01:50 UTC |
Reynoso Jamie L.CEO of Medicare Advantage
|
Tax withholdingClass A Common Stock | 15,830 | $3.16 | $50,022.80 |
DisclosureSEC source: 0000895345-23-000252 · form4.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,437,766 F1 · shares: Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 16, 2021, on each of January 7, 2022 and January 7, 2023. The original grant was timely reported on a Form 4 filed on July 20, 2021. F2 · balance_after: The number of shares of the Issuer's Class A Common Stock reported as beneficially owned includes an adjustment from the most recent Form 4 filing to reflect 1,281 shares of the Issuer's Class A Common Stock withheld by the Issuer to cover the Reporting Person's tax obligations in connection with a prior vesting event that was reported on a Form 4/A filed on the same date as this Form 4 report. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 18:22 UTC |
Palihapitiya Chamath10% owner · See Remarks
ChaChaCha SPAC C, LLC10% owner · Former Director
SCH Sponsor III LLC10% owner · Former Director
|
PurchaseClass A Common Stock | 1,739,130 | $5.75 | $9,999,997.50 |
DisclosureSEC source: 0001209191-21-066848 · doc4.xml · nonDerivative · entry 4 Palihapitiya Chamath · CIK 0001715450 · 10% owner · See Remarks ChaChaCha SPAC C, LLC · CIK 0001806665 · 10% owner · Former Director SCH Sponsor III LLC · CIK 0001806247 · 10% owner · Former Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SC Ventures Holdings, LLC Disclosed balance after: 1,739,130 F7 · ownership.nature: Reflects securities held by SC Ventures Holdings, LLC ("SC Ventures"). On the basis of Mr. Palihapitiya's relationship with SC Ventures, Mr. Palihapitiya may be deemed a beneficial owner of the Issuer securities held by SC Ventures. Mr. Palihapitiya disclaims beneficial ownership of the Issuer securities held by SC Ventures, except to the extent of his pecuniary interest therein. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 23:06 UTC |
GREENOAKS LLC10% owner · See Remarks
MEHTA NEIL10% owner
PERETZ BENJAMIN10% owner
|
OtherClass B Common Stock · Derivative | 24,333,120 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000902664-21-005107 · ownership.xml · derivative · entry 1 GREENOAKS CAPITAL PARTNERS LLC · CIK 0001840735 · 10% owner · See Remarks MEHTA NEIL · CIK 0001840890 · 10% owner PERETZ BENJAMIN · CIK 0001840428 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 25,754,556 Underlying: Class A Common Stock · 24,333,120 shares Expires not disclosed F1 · derivative.exercise_price: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · kind: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · shares: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · price: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · derivative.exercise_date: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · derivative.expiration_date: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F2 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Greenoaks Capital serves as the investment adviser and related persons or entities. Neil Mehta and Benjamin Peretz serve as Managing Directors of Greenoaks Capital. Read SEC document |
| September 08, 2021 Filed Sep 11, 2021 00:58 UTC |
GREENOAKS LLC10% owner
MEHTA NEIL10% owner
PERETZ BENJAMIN10% owner
|
OtherClass B Common Stock · Derivative | 24,624,561 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000902664-21-004188 · ownership.xml · derivative · entry 1 GREENOAKS CAPITAL PARTNERS LLC · CIK 0001840735 · 10% owner MEHTA NEIL · CIK 0001840890 · 10% owner PERETZ BENJAMIN · CIK 0001840428 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 50,087,676 Underlying: Class A Common Stock · 24,624,561 shares Expires not disclosed F1 · derivative.exercise_price: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · kind: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · shares: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · price: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · derivative.exercise_date: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · derivative.expiration_date: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F3 · balance_after: The Form 4 filed by the Reporting Persons on July 8, 2021 reported a pro-rata in-kind distribution of 21,463,951 shares. The Reporting Persons in fact distributed 21,619,101 shares. The number of shares set forth on this line reflects such correction. F2 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Greenoaks Capital serves as the investment adviser and related persons or entities. Neil Mehta and Benjamin Peretz serve as Managing Directors of Greenoaks Capital. Read SEC document |
| August 20, 2021 Filed Nov 24, 2021 18:22 UTC |
Palihapitiya Chamath10% owner · See Remarks
ChaChaCha SPAC C, LLC10% owner · Former Director
SCH Sponsor III LLC10% owner · Former Director
|
OtherClass A Common Stock | 750,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-066848 · doc4.xml · nonDerivative · entry 3 Palihapitiya Chamath · CIK 0001715450 · 10% owner · See Remarks ChaChaCha SPAC C, LLC · CIK 0001806665 · 10% owner · Former Director SCH Sponsor III LLC · CIK 0001806247 · 10% owner · Former Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By ChaChaCha SPAC C LLC Disclosed balance after: 28,408,480 F6 · kind: Reflects a distribution of shares by ChaChaCha for no value. F5 · ownership.nature: Reflects securities held by ChaChaCha. On the basis of Mr. Palihapitiya's relationship with ChaChaCha, Mr. Palihapitiya may be deemed a beneficial owner of the Issuer securities held by ChaChaCha. Mr. Palihapitiya disclaims beneficial ownership of the Issuer securities held by ChaChaCha, except to the extent of his pecuniary interest therein. Read SEC document |
| August 16, 2021 Filed Nov 24, 2021 18:22 UTC |
Palihapitiya Chamath10% owner · See Remarks
ChaChaCha SPAC C, LLC10% owner · Former Director
SCH Sponsor III LLC10% owner · Former Director
|
Exercise / conversionWarrants · Derivative | 9,020,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-066848 · doc4.xml · derivative · entry 6 Palihapitiya Chamath · CIK 0001715450 · 10% owner · See Remarks ChaChaCha SPAC C, LLC · CIK 0001806665 · 10% owner · Former Director SCH Sponsor III LLC · CIK 0001806247 · 10% owner · Former Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By ChaChaCha SPAC C LLC Disclosed balance after: 0 Underlying: Class A Common Stock · 2,245,980 shares Expires 2026-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These warrants were exercised in a "Make-Whole Exercise" prior to a redemption of such warrants by the Issuer. Pursuant to the terms of the warrants relating to a Make-Whole Exercise, the warrants held by ChaChaCha were exercised for 2,245,980 shares of Issuer common stock. F9 · shares: Prior to the exercise of the warrants reported herein, these warrants were received by ChaChaCha as part of a pro rata distribution from the Sponsor, which was exempt under Rules 16a-9 and 16a-13 under the Securities Exchange Act of 1934, as amended. F1 · price: Reflects a distribution of securities by SCH Sponsor III LLC (the "Sponsor") made to its members on a pro rata basis. F8 · derivative.exercise_date: These warrants were fully vested and exercisable. F3 · derivative.underlying_shares: These warrants were exercised in a "Make-Whole Exercise" prior to a redemption of such warrants by the Issuer. Pursuant to the terms of the warrants relating to a Make-Whole Exercise, the warrants held by ChaChaCha were exercised for 2,245,980 shares of Issuer common stock. F5 · ownership.nature: Reflects securities held by ChaChaCha. On the basis of Mr. Palihapitiya's relationship with ChaChaCha, Mr. Palihapitiya may be deemed a beneficial owner of the Issuer securities held by ChaChaCha. Mr. Palihapitiya disclaims beneficial ownership of the Issuer securities held by ChaChaCha, except to the extent of his pecuniary interest therein. Read SEC document |
| August 16, 2021 Filed Nov 24, 2021 18:22 UTC |
Palihapitiya Chamath10% owner · See Remarks
ChaChaCha SPAC C, LLC10% owner · Former Director
SCH Sponsor III LLC10% owner · Former Director
|
Exercise / conversionClass A Common Stock | 2,245,980 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-066848 · doc4.xml · nonDerivative · entry 2 Palihapitiya Chamath · CIK 0001715450 · 10% owner · See Remarks ChaChaCha SPAC C, LLC · CIK 0001806665 · 10% owner · Former Director SCH Sponsor III LLC · CIK 0001806247 · 10% owner · Former Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By ChaChaCha SPAC C LLC Disclosed balance after: 29,158,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: These warrants were exercised in a "Make-Whole Exercise" prior to a redemption of such warrants by the Issuer. Pursuant to the terms of the warrants relating to a Make-Whole Exercise, the warrants held by ChaChaCha were exercised for 2,245,980 shares of Issuer common stock. F3 · price: These warrants were exercised in a "Make-Whole Exercise" prior to a redemption of such warrants by the Issuer. Pursuant to the terms of the warrants relating to a Make-Whole Exercise, the warrants held by ChaChaCha were exercised for 2,245,980 shares of Issuer common stock. F4 · balance_after: Includes shares of Issuer common stock received by ChaChaCha as part of a pro rata distribution from the Sponsor, which was exempt under Rules 16a-9 and 16a-13 under the Securities Exchange Act of 1934, as amended. F5 · ownership.nature: Reflects securities held by ChaChaCha. On the basis of Mr. Palihapitiya's relationship with ChaChaCha, Mr. Palihapitiya may be deemed a beneficial owner of the Issuer securities held by ChaChaCha. Mr. Palihapitiya disclaims beneficial ownership of the Issuer securities held by ChaChaCha, except to the extent of his pecuniary interest therein. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:18 UTC |
Wagner Joseph F.Chief Financial Officer
|
ConversionClass B Common Stock · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-032568 · doc4.xml · derivative · entry 4 Wagner Joseph F. · CIK 0001839810 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. F1 · derivative.exercise_date: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. F1 · derivative.expiration_date: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:18 UTC |
Wagner Joseph F.Chief Financial Officer
|
Exercise / conversionClass B Common Stock · Derivative | 25,000 | $0.00 Strike: $2.23 | $0.00 |
DisclosureSEC source: 0000899243-21-032568 · doc4.xml · derivative · entry 3 Wagner Joseph F. · CIK 0001839810 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. F1 · derivative.expiration_date: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:18 UTC |
Wagner Joseph F.Chief Financial Officer
|
Exercise / conversionStock Options (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.23 | $0.00 |
DisclosureSEC source: 0000899243-21-032568 · doc4.xml · derivative · entry 2 Wagner Joseph F. · CIK 0001839810 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,018 Underlying: Class B Common Stock · 25,000 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the stock option is immediately exercisable. The stock option vested as to 1/5th of the total number of shares on December 30, 2020 and continues to vest as to 1/60th of the total number of shares in equal monthly installments thereafter, subject to the continuous service of the Reporting Person on each vesting date. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:18 UTC |
Wagner Joseph F.Chief Financial Officer
|
ConversionClass A Common Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-032568 · doc4.xml · nonDerivative · entry 1 Wagner Joseph F. · CIK 0001839810 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| July 16, 2021 Filed Jul 21, 2021 01:50 UTC |
Reynoso Jamie L.Chief Operating Officer
|
GrantClass A Common Stock | 220,820 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-029107 · doc4.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,820 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in equal annual installments over four years, beginning on January 7, 2022, subject to the continuous service of the Reporting Person on each vesting date. Read SEC document |
| July 08, 2021 Filed Jul 12, 2021 19:09 UTC |
Singh PrabhdeepChief Growth Officer
|
GrantClass A Common Stock | 52,798 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046356 · doc4.xml · nonDerivative · entry 2 Singh Prabhdeep · CIK 0001870027 · Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,991 F2 · shares: Represents shares of Class A common stock underlying RSUs. The RSUs will vest in full on July 6, 2022, subject to the continuous service of the Reporting Person on such vesting date. Read SEC document |
| July 08, 2021 Filed Jul 12, 2021 19:09 UTC |
Singh PrabhdeepChief Growth Officer
|
GrantClass A Common Stock | 211,193 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046356 · doc4.xml · nonDerivative · entry 1 Singh Prabhdeep · CIK 0001870027 · Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,193 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in equal annual installments over four years, beginning on July 6, 2022, subject to the continuous service of the Reporting Person on each vesting date. Read SEC document |
| July 07, 2021 Filed Nov 24, 2021 18:22 UTC |
Palihapitiya Chamath10% owner · See Remarks
ChaChaCha SPAC C, LLC10% owner · Former Director
SCH Sponsor III LLC10% owner · Former Director
|
OtherWarrants · Derivative | 10,933,333 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001209191-21-066848 · doc4.xml · derivative · entry 5 Palihapitiya Chamath · CIK 0001715450 · 10% owner · See Remarks ChaChaCha SPAC C, LLC · CIK 0001806665 · 10% owner · Former Director SCH Sponsor III LLC · CIK 0001806247 · 10% owner · Former Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SCH Sponsor III LLC Disclosed balance after: 0 Underlying: Class A Common Stock · 10,933,333 shares Expires 2026-01-07 F1 · kind: Reflects a distribution of securities by SCH Sponsor III LLC (the "Sponsor") made to its members on a pro rata basis. F1 · price: Reflects a distribution of securities by SCH Sponsor III LLC (the "Sponsor") made to its members on a pro rata basis. F8 · derivative.exercise_date: These warrants were fully vested and exercisable. F2 · ownership.nature: Reflects securities held by the Sponsor. Messrs. Chamath Palihapitiya and Ian Osborne and ChaChaCha SPAC C LLC ("ChaChaCha") may be deemed to beneficially own the Issuer securities held by the Sponsor on the basis of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Osborne and ChaChaCha disclaims beneficial ownership of the Issuer securities held by the Sponsor, except to the extent of such person's pecuniary interest therein. Read SEC document |
| July 07, 2021 Filed Nov 24, 2021 18:22 UTC |
Palihapitiya Chamath10% owner · See Remarks
ChaChaCha SPAC C, LLC10% owner · Former Director
SCH Sponsor III LLC10% owner · Former Director
|
OtherClass A Common Stock | 20,500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-066848 · doc4.xml · nonDerivative · entry 1 Palihapitiya Chamath · CIK 0001715450 · 10% owner · See Remarks ChaChaCha SPAC C, LLC · CIK 0001806665 · 10% owner · Former Director SCH Sponsor III LLC · CIK 0001806247 · 10% owner · Former Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SCH Sponsor III LLC Disclosed balance after: 0 F1 · kind: Reflects a distribution of securities by SCH Sponsor III LLC (the "Sponsor") made to its members on a pro rata basis. F1 · price: Reflects a distribution of securities by SCH Sponsor III LLC (the "Sponsor") made to its members on a pro rata basis. F2 · ownership.nature: Reflects securities held by the Sponsor. Messrs. Chamath Palihapitiya and Ian Osborne and ChaChaCha SPAC C LLC ("ChaChaCha") may be deemed to beneficially own the Issuer securities held by the Sponsor on the basis of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Osborne and ChaChaCha disclaims beneficial ownership of the Issuer securities held by the Sponsor, except to the extent of such person's pecuniary interest therein. Read SEC document |
| July 06, 2021 Filed Jul 9, 2021 00:35 UTC |
GREENOAKS LLC10% owner
MEHTA NEIL10% owner
PERETZ BENJAMIN10% owner
|
OtherClass B Common Stock · Derivative | 21,463,951 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000902664-21-003395 · ownership.xml · derivative · entry 1 GREENOAKS CAPITAL PARTNERS LLC · CIK 0001840735 · 10% owner MEHTA NEIL · CIK 0001840890 · 10% owner PERETZ BENJAMIN · CIK 0001840428 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 74,867,387 Underlying: Class A Common Stock · 21,463,951 shares Expires not disclosed F1 · derivative.exercise_price: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · kind: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · shares: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · price: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · derivative.exercise_date: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · derivative.expiration_date: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F2 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Greenoaks Capital serves as the investment adviser and related persons or entities. Neil Mehta and Benjamin Peretz serve as Managing Directors of Greenoaks Capital. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 20:18 UTC |
Kouzoukas Demetrios L.Director
|
GrantRestricted Stock Unit · Derivative | 25,608 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026829 · doc4.xml · derivative · entry 1 Kouzoukas Demetrios L. · CIK 0001856511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,608 Underlying: Class A Common Stock · 25,608 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: 100% of the shares subject to the award shall vest on the date of the 2022 Annual Meeting, subject to Mr. Kouzoukas' continued service as a member of the Board through such vesting date. F2 · derivative.expiration_date: 100% of the shares subject to the award shall vest on the date of the 2022 Annual Meeting, subject to Mr. Kouzoukas' continued service as a member of the Board through such vesting date. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 18:07 UTC |
Robinson William G JrDirector
|
GrantRestricted Stock Unit · Derivative | 54,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-024771 · doc4.xml · derivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,200 Underlying: Class A Common Stock · 54,200 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: The RSUs will vest as to 50% of the shares subject to the award on the first anniversary of January 7, 2021, and will vest as to the remaining shares subject to the award on the date of the 2022 Annual Meeting, subject to the Reporting Person's continued service as a member of the Board through each such vesting date. F2 · derivative.expiration_date: The RSUs will vest as to 50% of the shares subject to the award on the first anniversary of January 7, 2021, and will vest as to the remaining shares subject to the award on the date of the 2022 Annual Meeting, subject to the Reporting Person's continued service as a member of the Board through each such vesting date. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 01:33 UTC |
Clinton ChelseaDirector
|
GrantRestricted Stock Unit · Derivative | 38,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-025541 · doc4.xml · derivative · entry 1 Clinton Chelsea · CIK 0001530920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,392 Underlying: Class A Common Stock · 38,392 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: 100% of the shares subject to the award shall vest on the date of the 2022 Annual Meeting, subject to Ms. Clinton's continued service as a member of the Board through such vesting date. F2 · derivative.expiration_date: 100% of the shares subject to the award shall vest on the date of the 2022 Annual Meeting, subject to Ms. Clinton's continued service as a member of the Board through such vesting date. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 01:36 UTC |
Turner Nathaniel S.Director
|
GrantRestricted Stock Unit · Derivative | 38,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-025544 · doc4.xml · derivative · entry 1 Turner Nathaniel S. · CIK 0001838734 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,392 Underlying: Class A Common Stock · 38,392 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: 100% of the shares subject to the award shall vest on the date of the 2022 Annual Meeting, subject to Mr. Turner's continued service as a member of the Board through such vesting date. F2 · derivative.expiration_date: 100% of the shares subject to the award shall vest on the date of the 2022 Annual Meeting, subject to Mr. Turner's continued service as a member of the Board through such vesting date. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 12:43 UTC |
SHAPIRO LEEDirector
|
GrantRestricted Stock Unit · Derivative | 54,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-025578 · doc4.xml · derivative · entry 1 SHAPIRO LEE · CIK 0001213350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,200 Underlying: Class A Common Stock · 54,200 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: The RSUs will vest as to 50% of the shares subject to the award on the first anniversary of January 7, 2021, and will vest as to the remaining shares subject to the award on the date of the 2022 Annual Meeting, subject to the Reporting Person's continued service as a member of the Board through each such vesting date. F2 · derivative.expiration_date: The RSUs will vest as to 50% of the shares subject to the award on the first anniversary of January 7, 2021, and will vest as to the remaining shares subject to the award on the date of the 2022 Annual Meeting, subject to the Reporting Person's continued service as a member of the Board through each such vesting date. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 18:38 UTC |
Palihapitiya Chamath10% owner · See Remarks
SCH Sponsor III LLC10% owner
ChaChaCha SPAC C, LLC10% owner
|
GrantClass B Common Stock · Derivative | 284,891 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-001391 · doc4.xml · derivative · entry 4 Palihapitiya Chamath · CIK 0001715450 · 10% owner · See Remarks SCH Sponsor III LLC · CIK 0001806247 · 10% owner ChaChaCha SPAC C, LLC · CIK 0001806665 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By The Social+Capital Partnership III, L.P. Disclosed balance after: 0 Underlying: Class A Common Stock · 284,891 shares Expires not disclosed F4 · derivative.exercise_price: Pursuant to the consummation of the Business Combination, each share of common stock, par value $0.0001 per share, of Clover Health Investments, Corp. was converted into the right to receive a certain amount of shares of the Issuer's Class B common stock, par value $0.0001 per share ("Class B Shares"), in accordance with the Agreement and Plan of Merger, dated as of October 5, 2020, by and among SCH, Clover Health Investments, Corp. and Asclepius Merger Sub Inc., as amended on December 8, 2020. F4 · derivative.exercise_date: Pursuant to the consummation of the Business Combination, each share of common stock, par value $0.0001 per share, of Clover Health Investments, Corp. was converted into the right to receive a certain amount of shares of the Issuer's Class B common stock, par value $0.0001 per share ("Class B Shares"), in accordance with the Agreement and Plan of Merger, dated as of October 5, 2020, by and among SCH, Clover Health Investments, Corp. and Asclepius Merger Sub Inc., as amended on December 8, 2020. F4 · derivative.expiration_date: Pursuant to the consummation of the Business Combination, each share of common stock, par value $0.0001 per share, of Clover Health Investments, Corp. was converted into the right to receive a certain amount of shares of the Issuer's Class B common stock, par value $0.0001 per share ("Class B Shares"), in accordance with the Agreement and Plan of Merger, dated as of October 5, 2020, by and among SCH, Clover Health Investments, Corp. and Asclepius Merger Sub Inc., as amended on December 8, 2020. F5 · ownership.nature: On the basis of the reporting person's relationship with The Social + Capital Partnership III, L.P., the reporting person may be deemed a beneficial owner of the shares of the Issuer's Class B Shares held by The Social + Capital Partnership III, L.P., for itself and as nominee for The Social + Capital Partnership Principals Fund III, L.P. The reporting person disclaims beneficial ownership of the Class B Shares held by The Social + Capital Partnership III, L.P., except to the extent of his pecuniary interest therein. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 18:38 UTC |
Palihapitiya Chamath10% owner · See Remarks
SCH Sponsor III LLC10% owner
ChaChaCha SPAC C, LLC10% owner
|
Exercise / conversionClass B ordinary share · Derivative | 20,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-001391 · doc4.xml · derivative · entry 3 Palihapitiya Chamath · CIK 0001715450 · 10% owner · See Remarks SCH Sponsor III LLC · CIK 0001806247 · 10% owner ChaChaCha SPAC C, LLC · CIK 0001806665 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SCH Sponsor III LLC Disclosed balance after: 0 Underlying: Class A Common Stock · 20,500,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one Class A Share. F2 · derivative.exercise_date: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one Class A Share. F2 · derivative.expiration_date: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one Class A Share. F3 · ownership.nature: A majority of the voting interests of SCH Sponsor III LLC ("Sponsor") are held by ChaChaCha. Messrs. Chamath Palihapitiya and Ian Osborne and ChaChaCha may be deemed to beneficially own the Class A Shares held by the Sponsor on the basis of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Osborne and ChaChaCha disclaims beneficial ownership of the Class A Shares held by the Sponsor, except to the extent of such person's pecuniary interest therein. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 18:38 UTC |
Palihapitiya Chamath10% owner · See Remarks
SCH Sponsor III LLC10% owner
ChaChaCha SPAC C, LLC10% owner
|
Exercise / conversionClass A Common Stock | 20,500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-001391 · doc4.xml · nonDerivative · entry 2 Palihapitiya Chamath · CIK 0001715450 · 10% owner · See Remarks SCH Sponsor III LLC · CIK 0001806247 · 10% owner ChaChaCha SPAC C, LLC · CIK 0001806665 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SCH Sponsor III LLC Disclosed balance after: 30,500,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one Class A Share. F3 · ownership.nature: A majority of the voting interests of SCH Sponsor III LLC ("Sponsor") are held by ChaChaCha. Messrs. Chamath Palihapitiya and Ian Osborne and ChaChaCha may be deemed to beneficially own the Class A Shares held by the Sponsor on the basis of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Osborne and ChaChaCha disclaims beneficial ownership of the Class A Shares held by the Sponsor, except to the extent of such person's pecuniary interest therein. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 18:38 UTC |
Palihapitiya Chamath10% owner · See Remarks
SCH Sponsor III LLC10% owner
ChaChaCha SPAC C, LLC10% owner
|
GrantClass A Common Stock | 10,000,000 | $10.00 | $100,000,000.00 |
DisclosureSEC source: 0000899243-21-001391 · doc4.xml · nonDerivative · entry 1 Palihapitiya Chamath · CIK 0001715450 · 10% owner · See Remarks SCH Sponsor III LLC · CIK 0001806247 · 10% owner ChaChaCha SPAC C, LLC · CIK 0001806665 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By ChaChaCha SPAC C LLC Disclosed balance after: 10,000,000 F1 · ownership.nature: On the basis of the reporting person's relationship with ChaChaCha SPAC C LLC ("ChaChaCha"), the reporting person may be deemed a beneficial owner of the shares of the Issuer's Class A common stock, par value $0.0001 per share ("Class A Shares"), held by ChaChaCha. The reporting person disclaims beneficial ownership of the Class A Shares held by ChaChaCha, except to the extent of his pecuniary interest therein. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:23 UTC |
Clinton ChelseaDirector
|
GrantStock Options (right to buy) · Derivative | 186,300 | Not disclosed Strike: $8.42 | Not disclosed |
DisclosureSEC source: 0001209191-21-003170 · doc4.xml · derivative · entry 2 Clinton Chelsea · CIK 0001530920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,300 Underlying: Class B Common Stock · 186,300 shares Expires 2030-10-29 F5 · price: Received in connection with the Business Combination in exchange for options to acquire 90,084 shares of common stock of Legacy Clover for $17.42 per share. F4 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:23 UTC |
Clinton ChelseaDirector
|
GrantStock Options (right to buy) · Derivative | 499,390 | Not disclosed Strike: $1.26 | Not disclosed |
DisclosureSEC source: 0001209191-21-003170 · doc4.xml · derivative · entry 1 Clinton Chelsea · CIK 0001530920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 499,390 Underlying: Class B Common Stock · 499,390 shares Expires 2027-02-07 F3 · price: Received in connection with the Issuer's business combination (the "Business Combination") with Clover Health Investments, Corp. ("Legacy Clover") in accordance with the terms of the Agreement and Plan of Merger dated as of October 5, 2020, among the Issuer (f/k/a Social Capital Hedosophia Holdings Corp. III), Asclepius Merger Sub Inc., and Legacy Clover, as amended by that certain Amendment to the Agreement and Plan of Merger, dated as of December 8, 2020, in exchange for options to acquire 241,476 shares of common stock of Legacy Clover for $2.61 per share. F1 · derivative.exercise_date: 100% of the stock option is immediately exercisable. The stock option vests as to 1/5th of the total number of shares in equal annual installments beginning on January 31, 2018, subject to the continuous service of the Reporting Person on each vesting date. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 23:17 UTC |
Reses Jacqueline DFORMER DIRECTOR
|
Exercise / conversionClass B ordinary share · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-001382 · doc4.xml · derivative · entry 3 Reses Jacqueline D · CIK 0001699681 · FORMER DIRECTOR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 100,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one share of the Issuer's Class A common stock, par value $0.0001 per share. F1 · derivative.exercise_date: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one share of the Issuer's Class A common stock, par value $0.0001 per share. F1 · derivative.expiration_date: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one share of the Issuer's Class A common stock, par value $0.0001 per share. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 23:17 UTC |
Reses Jacqueline DFORMER DIRECTOR
|
GrantClass A Common Stock | 200,000 | $10.00 | $2,000,000.00 |
DisclosureSEC source: 0000899243-21-001382 · doc4.xml · nonDerivative · entry 2 Reses Jacqueline D · CIK 0001699681 · FORMER DIRECTOR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 23:17 UTC |
Reses Jacqueline DFORMER DIRECTOR
|
Exercise / conversionClass A Common Stock | 100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-001382 · doc4.xml · nonDerivative · entry 1 Reses Jacqueline D · CIK 0001699681 · FORMER DIRECTOR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one share of the Issuer's Class A common stock, par value $0.0001 per share. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 18:25 UTC |
Osborne Ian10% owner · FORMER PRESIDENT AND DIRECTOR
|
Exercise / conversionClass B ordinary share · Derivative | 20,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-001387 · doc4.xml · derivative · entry 3 Osborne Ian · CIK 0001715393 · 10% owner · FORMER PRESIDENT AND DIRECTOR 10b5-1 filing: Not disclosed Ownership: Indirect · By SCH Sponsor III LLC Disclosed balance after: 0 Underlying: Class A Common Stock · 20,500,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one Class A Share. F2 · derivative.exercise_date: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one Class A Share. F2 · derivative.expiration_date: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one Class A Share. F3 · ownership.nature: A majority of the voting interests of SCH Sponsor III LLC ("Sponsor") are held by ChaChaCha SPAC C LLC ("ChaChaCha"). Messrs. Chamath Palihapitiya and Ian Osborne and ChaChaCha may be deemed to beneficially own the Class A Shares held by the Sponsor on the basis of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Osborne and ChaChaCha disclaims beneficial ownership of the Class A Shares held by the Sponsor, except to the extent of such person's pecuniary interest therein. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 18:25 UTC |
Osborne Ian10% owner · FORMER PRESIDENT AND DIRECTOR
|
Exercise / conversionClass A Common Stock | 20,500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-001387 · doc4.xml · nonDerivative · entry 2 Osborne Ian · CIK 0001715393 · 10% owner · FORMER PRESIDENT AND DIRECTOR 10b5-1 filing: Not disclosed Ownership: Indirect · By SCH Sponsor III LLC Disclosed balance after: 25,500,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one Class A Share. F3 · ownership.nature: A majority of the voting interests of SCH Sponsor III LLC ("Sponsor") are held by ChaChaCha SPAC C LLC ("ChaChaCha"). Messrs. Chamath Palihapitiya and Ian Osborne and ChaChaCha may be deemed to beneficially own the Class A Shares held by the Sponsor on the basis of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Osborne and ChaChaCha disclaims beneficial ownership of the Class A Shares held by the Sponsor, except to the extent of such person's pecuniary interest therein. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 18:25 UTC |
Osborne Ian10% owner · FORMER PRESIDENT AND DIRECTOR
|
GrantClass A Common Stock | 5,000,000 | $10.00 | $50,000,000.00 |
DisclosureSEC source: 0000899243-21-001387 · doc4.xml · nonDerivative · entry 1 Osborne Ian · CIK 0001715393 · 10% owner · FORMER PRESIDENT AND DIRECTOR 10b5-1 filing: Not disclosed Ownership: Indirect · By Hedosophia Public Investments Limited Disclosed balance after: 5,000,000 F1 · ownership.nature: On the basis of the reporting person's relationship with Hedosophia Public Investments Limited, the reporting person may be deemed a beneficial owner of the shares of the Issuer's Class A common stock, par value $0.0001 per share ("Class A Shares"), held by Hedosophia Public Investments Limited. The reporting person disclaims beneficial ownership of the Shares held by Hedosophia Public Investments Limited, except to the extent of his pecuniary interest therein. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 18:18 UTC |
Ryans JamesFORMER DIRECTOR
|
Exercise / conversionClass B ordinary share · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-001383 · doc4.xml · derivative · entry 2 Ryans James · CIK 0001724596 · FORMER DIRECTOR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 100,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one share of the Issuer's Class A common stock, par value $0.0001 per share. F1 · derivative.exercise_date: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one share of the Issuer's Class A common stock, par value $0.0001 per share. F1 · derivative.expiration_date: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one share of the Issuer's Class A common stock, par value $0.0001 per share. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 18:18 UTC |
Ryans JamesFORMER DIRECTOR
|
Exercise / conversionClass A Common Stock | 100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-001383 · doc4.xml · nonDerivative · entry 1 Ryans James · CIK 0001724596 · FORMER DIRECTOR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one share of the Issuer's Class A common stock, par value $0.0001 per share. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:18 UTC |
Wagner Joseph F.Chief Financial Officer
|
GrantStock Options (right to buy) · Derivative | 125,496 | Not disclosed Strike: $5.41 | Not disclosed |
DisclosureSEC source: 0001209191-21-003167 · doc4.xml · derivative · entry 2 Wagner Joseph F. · CIK 0001839810 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,496 Underlying: Class B Common Stock · 125,496 shares Expires 2030-08-21 F4 · price: Received in connection with the Business Combination in exchange for options to acquire 60,683 shares of common stock of Legacy Clover for $11.19 per share. F1 · derivative.exercise_date: 100% of the stock option is immediately exercisable. The stock option vests as to 1/5th of the total number of shares on December 30, 2020 and 1/60th of the total number of shares in equal monthly installments thereafter, subject to the continuous service of the Reporting Person on each vesting date. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:18 UTC |
Wagner Joseph F.Chief Financial Officer
|
GrantStock Options (right to buy) · Derivative | 517,018 | Not disclosed Strike: $2.23 | Not disclosed |
DisclosureSEC source: 0001209191-21-003167 · doc4.xml · derivative · entry 1 Wagner Joseph F. · CIK 0001839810 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 517,018 Underlying: Class B Common Stock · 517,018 shares Expires 2030-02-03 F3 · price: Received in connection with the Issuer's business combination (the "Business Combination") with Clover Health Investments, Corp. ("Legacy Clover") in accordance with the terms of the Agreement and Plan of Merger dated as of October 5, 2020, among the Issuer (f/k/a Social Capital Hedosophia Holdings Corp. III), Asclepius Merger Sub Inc., and Legacy Clover, as amended by that certain Amendment to the Agreement and Plan of Merger, dated as of December 8, 2020, in exchange for options to acquire 250,000 shares of common stock of Legacy Clover for $4.61 per share. F1 · derivative.exercise_date: 100% of the stock option is immediately exercisable. The stock option vests as to 1/5th of the total number of shares on December 30, 2020 and 1/60th of the total number of shares in equal monthly installments thereafter, subject to the continuous service of the Reporting Person on each vesting date. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:17 UTC |
Turner Nathaniel S.Director
|
GrantClass B Common Stock · Derivative | 2,565,954 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-003166 · doc4.xml · derivative · entry 1 Turner Nathaniel S. · CIK 0001838734 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Multiple Holdings, LLC Disclosed balance after: 2,565,954 Underlying: Class A Common Stock · 2,565,954 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. F2 · price: Received in connection with the Issuer's business combination (the "Business Combination") with Clover Health Investments, Corp. ("Legacy Clover") in accordance with the terms of the Agreement and Plan of Merger dated as of October 5, 2020, among the Issuer (f/k/a Social Capital Hedosophia Holdings Corp. III), Asclepius Merger Sub Inc., and Legacy Clover, as amended by that certain Amendment to the Agreement and Plan of Merger, dated as of December 8, 2020, in exchange for 1,330,273 shares of common stock of Legacy Clover. F1 · derivative.exercise_date: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. F1 · derivative.expiration_date: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. F3 · ownership.nature: The Reporting Person is a partner in Multiple Holdings, LLC and may be deemed to share voting power and dispositive power over the shares held by Multiple Holdings, LLC. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:16 UTC |
Toy AndrewDirector · President and CTO
|
GrantPerformance-based Restricted Stock Units · Derivative | 11,142,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-003164 · doc4.xml · derivative · entry 6 Toy Andrew · CIK 0001838733 · Director · President and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,142,328 Underlying: Class B Common Stock · 11,142,328 shares Expires not disclosed F9 · derivative.exercise_price: Each performance-based restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited. F9 · derivative.exercise_date: Each performance-based restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited. F9 · derivative.expiration_date: Each performance-based restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:16 UTC |
Toy AndrewDirector · President and CTO
|
GrantPerformance-based Restricted Stock Units · Derivative | 3,582,291 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-003164 · doc4.xml · derivative · entry 5 Toy Andrew · CIK 0001838733 · Director · President and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,582,291 Underlying: Class B Common Stock · 3,582,291 shares Expires not disclosed F9 · derivative.exercise_price: Each performance-based restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited. F10 · price: Received in connection with the Business Combination in exchange for restricted stock units that will have settled for 1,732,187 shares of common stock of Legacy Clover. F9 · derivative.exercise_date: Each performance-based restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited. F9 · derivative.expiration_date: Each performance-based restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:16 UTC |
Toy AndrewDirector · President and CTO
|
GrantStock Options (right to buy) · Derivative | 3,669,607 | Not disclosed Strike: $5.45 | Not disclosed |
DisclosureSEC source: 0001209191-21-003164 · doc4.xml · derivative · entry 4 Toy Andrew · CIK 0001838733 · Director · President and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,669,607 Underlying: Class B Common Stock · 3,669,607 shares Expires 2030-02-03 F8 · price: Received in connection with the Business Combination in exchange for options to acquire 1,774,408 shares of common stock of Legacy Clover for $11.27 per share. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:16 UTC |
Toy AndrewDirector · President and CTO
|
GrantStock Options (right to buy) · Derivative | 5,334,515 | Not disclosed Strike: $2.23 | Not disclosed |
DisclosureSEC source: 0001209191-21-003164 · doc4.xml · derivative · entry 3 Toy Andrew · CIK 0001838733 · Director · President and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,334,515 Underlying: Class B Common Stock · 5,334,515 shares Expires 2030-02-03 F7 · price: Received in connection with the Business Combination in exchange for options to acquire 2,579,460 shares of common stock of Legacy Clover for $4.61 per share. F6 · derivative.exercise_date: The option vested as to 1/60th of the total number of shares on July 1, 2019, and thereafter vested and shall continue to vest as to 1/60th of the total number of shares in equal monthly installments. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:16 UTC |
Toy AndrewDirector · President and CTO
|
GrantStock Options (right to buy) · Derivative | 3,155,168 | Not disclosed Strike: $1.67 | Not disclosed |
DisclosureSEC source: 0001209191-21-003164 · doc4.xml · derivative · entry 2 Toy Andrew · CIK 0001838733 · Director · President and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,155,168 Underlying: Class B Common Stock · 3,155,168 shares Expires 2028-07-21 F5 · price: Received in connection with the Business Combination in exchange for options to acquire 1,525,655 shares of common stock of Legacy Clover for $3.45 per share. F4 · derivative.exercise_date: 100% of the stock option is immediately exercisable. The stock option vests as to 1/5th of the total number of shares on February 5, 2019 and 1/60th of the total number of shares in equal monthly installments thereafter, subject to the continuous service of the Reporting Person on each vesting date. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:16 UTC |
Toy AndrewDirector · President and CTO
|
GrantStock Options (right to buy) · Derivative | 631,033 | Not disclosed Strike: $1.67 | Not disclosed |
DisclosureSEC source: 0001209191-21-003164 · doc4.xml · derivative · entry 1 Toy Andrew · CIK 0001838733 · Director · President and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 631,033 Underlying: Class B Common Stock · 631,033 shares Expires 2028-07-21 F3 · price: Received in connection with the Issuer's business combination (the "Business Combination") with Clover Health Investments, Corp. ("Legacy Clover") in accordance with the terms of the Agreement and Plan of Merger dated as of October 5, 2020, among the Issuer (f/k/a Social Capital Hedosophia Holdings Corp. III), Asclepius Merger Sub Inc., and Legacy Clover, as amended by that certain Amendment to the Agreement and Plan of Merger, dated as of December 8, 2020, in exchange for options to acquire 305,131 shares of common stock of Legacy Clover for $3.45 per share. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:15 UTC |
Reynoso Jamie L.Chief Operating Officer
|
GrantStock Options (right to buy) · Derivative | 465,316 | Not disclosed Strike: $4.67 | Not disclosed |
DisclosureSEC source: 0001209191-21-003163 · doc4.xml · derivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465,316 Underlying: Class B Common Stock · 465,316 shares Expires 2030-07-26 F5 · price: Received in connection with the Business Combination in exchange for options to acquire 225,000 shares of common stock of Legacy Clover for $9.66 per share. F4 · derivative.exercise_date: 100% of the stock option is immediately exercisable. The stock option vests as to 1/5th of the total number of shares on July 27, 2021 and 1/60th of the total number of shares in equal monthly installments thereafter, subject to the continuous service of the Reporting Person on each vesting date. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.